CHRSCoherus Oncology, Inc.vs its industry peers
A metric-by-metric comparison of Coherus Oncology, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CHRSEsta | $223M#10 | 0.9x#1 | 2.8x#9 | 5.3x#3 | 59.8%#1 | 489.4%#1 | -429.5%#8 | 213.7%#1 | -488.9%#4 | — | 64.4%#1 | — |
| IKT | $298M#1 | — | 1.8x#5 | — | -100.0%#10 | -75.4%#10 | — | -28.8%#4 | — | — | — | — |
| FATE | $291M#2 | — | 1.6x#4 | 43.8x#9 | -51.2%#8 | 26.8%#5 | -2222.4%#11 | -75.9%#11 | -90.3%#2 | — | — | — |
| LCTX | $277M#4 | — | 5.1x#12 | 19.0x#7 | 53.2%#2 | -241.4%#12 | -251.6%#5 | -117.9%#13 | — | — | — | — |
| AVXL | $272M#5 | — | 2.1x#6 | — | — | -7.8%#6 | — | -36.6%#7 | — | — | -73.8%#2 | — |
| ARTV | $258M#6 | — | 2.9x#10 | — | -100.0%#10 | -28.3%#7 | — | -95.5%#12 | — | — | — | — |
| EDIT | $256M#7 | — | 58.1x#14 | 6.3x#5 | 25.4%#3 | 32.5%#4 | -394.9%#7 | -3631.1%#14 | — | — | — | — |
| SRZN | $256M#8 | — | — | 73.5x#10 | -67.4%#9 | -280.8%#13 | -1210.6%#9 | — | — | — | — | — |
| TARA | $224M#9 | — | 1.2x#2 | 76.1x#11 | — | -28.7%#8 | -2189.6%#10 | -31.7%#5 | — | — | — | — |
| CRIS | $211M#11 | — | 16.6x#13 | 22.4x#8 | -13.4%#5 | 82.5%#3 | -60.5%#2 | -59.7%#8 | -123.5%#3 | — | — | — |
| SABS | $290M#3 | — | 1.3x#3 | — | -100.0%#10 | 138.9%#2 | — | 5.8%#2 | — | — | — | — |
| PLX | $191M#12 | 12.4x#2 | 2.8x#8 | 3.6x#1 | -1.2%#4 | -325.2%#14 | -10.4%#1 | -9.8%#3 | -20.3%#1 | 3#1 | — | — |
| ARMP | $179879#16 | — | — | — | — | -818.8%#16 | — | — | — | — | — | 44.5%#1 |
| ACOG | $178M#15 | — | 3.1x#11 | 17.4x#6 | — | -39.8%#9 | -221.7%#4 | -36.0%#6 | — | — | — | — |
| VYGR | $180M#14 | — | 1.0x#1 | 4.5x#2 | -49.5%#6 | -84.2%#11 | -326.6%#6 | -68.9%#10 | — | — | — | — |
| DTIL | $183M#13 | — | 2.4x#7 | 5.4x#4 | -50.1%#7 | -738.0%#15 | -152.2%#3 | -60.1%#9 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-08-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice